Lucid Diagnostics Inc.

NasdaqCM:LUCD

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 120.10 M

Share Price

USD 1.11

Avg Daily Volume

1,370,590

Change (1 day)

0.91%

Change (1 year)

Change (YTD)

24.72%

Lucid Diagnostics Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023: USD -60.12 M

Lucid Diagnostics Inc. EBIT is USD -60.12 M for the Trailing 12 Months (TTM) ending March 31, 2023. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Lucid Diagnostics Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -14.47 M.

Competitors

Roche Holding AG

USD 345.06

RO.SW

-6.70 -1.91%

Abbott Laboratories

USD 126.54

ABT

+0.90 0.72%

Thermo Fisher Scientific Inc.

USD 478.32

TMO

+3.29 0.69%

Boston Scientific Corporation

USD 106.14

BSX

-0.07 -0.07%

Siemens Healthineers AG

USD 56.32

SHL.DE

+0.05 0.09%

Becton, Dickinson and Company

USD 185.32

BDX

+1.69 0.92%

GE HealthCare Technologies Inc.

USD 77.61

GEHC

+0.84 1.09%

Agilent Technologies, Inc.

USD 120.18

-0.17 -0.14%

Laboratory Corporation of America Holdings

USD 264.96

-2.73 -1.02%

Natera, Inc.

USD 138.90

NTRA

-2.17 -1.54%

bioMérieux S.A.

USD 147.11

BIM.PA

-0.43 -0.29%

Baxter International Inc.

USD 29.22

BAX

+0.45 1.56%

Revvity, Inc.

USD 103.67

RVTY

+1.70 1.67%

Qiagen N.V.

USD 51.79

QGEN

+0.56 1.09%

Tempus AI, Inc.

USD 64.49

TEM

+1.15 1.82%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.33

603392.SS

-0.16 -1.87%

Exact Sciences Corporation

USD 48.49

EXAS

-0.28 -0.57%

ConvaTec Group Plc

USD 3.22

CTEC.L

-0.06 -1.98%

Globus Medical, Inc.

USD 54.48

GMED

+1.19 2.23%

Hangzhou Tigermed Consulting Co., Ltd.

USD 6.68

3347.HK

+0.28 4.38%

Key Data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)